KAROL POHLMAN REJMAN: Open Payments
NPI 1477547321 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,781 in 151 payments from 30 companies in 2025. Trend: 2023 $5,525 · 2024 $5,369 · 2025 $5,781
Food & beverage: $5,123Travel & lodging: $550Education: $108
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 12 | $1,183 |
| Medtronic, Inc. | 4 | $713 |
| Amgen Inc. | 30 | $618 |
| Novo Nordisk Inc | 15 | $505 |
| Insulet Corporation | 9 | $424 |
| Corcept Therapeutics | 10 | $334 |
| Lilly USA, LLC | 11 | $229 |
| Sequel Med Tech, LLC | 7 | $191 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $161 |
| Dexcom, Inc. | 1 | $142 |
Products named: REZDIFFRA, MINIMED 780G, OMNIPOD, TEPEZZA, Korlym, JARDIANCE, TWIIST, MOUNJARO.
Industry payments across NY — which companies pay providers there.
